sildenafil [orch, phsu]
Insulin Resistance [patf]
Human cells [lbtr]
Endothelial [tisu]
Efficacy [qlco]
Phosphodiesterase 5 Inhibitors [phsu]
RE [idcn]
establish [qlco]
Endothelial [tisu]
function [phsf]
Reduced [qlco]
diabetic [fndg]
Patients [podg]
Suggest [idcn]
therapy [ftcn]
Phosphodiesterase 5 Inhibitors [phsu]
i e [diap, inpr]
sildenafil [orch, phsu]
Nitric Oxide Synthase [aapp, enzy]
Proteins [aapp, bacs]
Heart [bpoc]
Cardiomyocytes [cell]
Study [mnob]
sildenafil [orch, phsu]
Endothelial Cells [cell]
Insulin Resistance [patf]
condition [dsyn]
In Vitro [inpr]
methodology [inpr]
Principal [qlco]
findings [ftcn]
Human Umbilical Vein Endothelial Cells [cell]
treated [topp]
Insulin [aapp, horm, phsu]
Glucose [bacs, carb, phsu]
mmHg [qnco]
Glucosamine [carb, phsu]
sildenafil [orch, phsu]
Insulin [aapp, horm, phsu]
Increased [qnco]
Phosphodiesterase-5 [aapp, enzy]
eNOS [aapp, enzy]
mRNA [bacs, nnon]
Assay [lbpr]
Real-Time PCR [mbrt]
sildenafil [orch, phsu]
Increased [qnco]
production [ocac]
Basal [spco]
condition [dsyn]
inhibited [qlco]
PI-3K [aapp, enzy]
Inhibitor [qlco]
LY 294002 [orch, phsu]
Completely [qlco]
inhibited [qlco]
Nitric Oxide Synthase Inhibitor [phsu]
Name [inpr]
AKT [aapp, enzy]
eNOS [aapp, enzy]
Activation [acty]
Reduced [qlco]
condition [dsyn]
Insulin Resistance [patf]
Completely [qlco]
sildenafil [orch, phsu]
treatment [ftcn]
sildenafil [orch, phsu]
treatment [ftcn]
Increasing [ftcn]
production [ocac]
eNOS [aapp, enzy]
Activation [acty]
Reducing [qlco]
Oxidative Stress [comd]
Induced [ftcn]
Hyperglycaemia [dsyn]
Glucosamine [carb, phsu]
Conclusions [idcn]
sildenafil [orch, phsu]
nitric-oxide synthase activity [moft]
Endothelial Cells [cell]
Insulin Resistance [patf]
condition [dsyn]
Suggest [idcn]
therapeutic use [topp]
sildenafil [orch, phsu]
Improving [qlco]
Vascular function [clna]
diabetic [fndg]
Patients [podg]
